top of page
A Robust Pipeline of
Disease-modifying
Medicines
Pipeline - Lead Development Candidate Programs
Target Overview - Lead Development Candidate Programs
ASHA-091 is a highly selective inhibitor of the key mitochondria regulatory protein DRP1. ASHA-091 restores mitochondria to a healthy functional state.
Mitochondrial dysfunction is a key driver of neurodegeneration and certain types of infectious and post-infection illness. ASHA-091 has broad therapeutic indications with demonstrate disease modifying efficacy and robust safety.
bottom of page